News
-
-
-
-
PRESS RELEASE
VALBIOTIS SA: Valbiotis receives double “Best Pharma Product 2027” award for its ValbiotisPRO® Cholestérol and ValbiotisPRO® Santé Métabolique solutions
Valbiotis receives double 'Best Pharma Product 2027' award for ValbiotisPRO® Cholestérol and ValbiotisPRO® Santé Métabolique. Recognition of ten years of research and development with patented active substances -
PRESS RELEASE
VALBIOTIS SA: Valbiotis receives double “Best Pharma Product 2027” award for its ValbiotisPRO® Cholestérol and ValbiotisPRO® Santé Métabolique solutions
Valbiotis receives double "Best Pharma Product 2027" award for its ValbiotisPRO® Cholestérol and ValbiotisPRO® Santé Métabolique solutions. The awards recognize ten years of research, patented ingredients, and strong positioning in the French pharmacy market -
-
-
REGULATED PRESS RELEASE
Declaration of transactions on own shares from October 12, 2026 to October 18, 2026
TRIGANO SA declares transactions on own shares from October 12 to October 18, 2026, presenting daily aggregated data by market. Annual results for 2025/2026 to be released on November 24, 2026 -
REGULATED PRESS RELEASE
Schneider Electric launches a c. €6.0 billion capital increase, without shareholders’ preferential subscription rights, to partially finance the acquisition of PTC Inc.
Schneider Electric launches a €6.0 billion capital increase without preferential subscription rights to partially finance the acquisition of PTC Inc. Proceeds will fund the Acquisition. Details on the Capital Increase are available in the Company's announcement -